Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL4266725 | 0.97 | TSHR (0.58) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL28280046 | 0.97 | TSHR (0.58) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL3278606 | 0.97 | LMNA (0.58) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL5725705 | 0.95 | TSHR (0.55) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL6659437 | 0.93 | LMNA (0.52) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL11302102 | 0.91 | LMNA (0.50) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL2152594 | 0.91 | KCNH2 (0.52) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL28533776 | 0.91 | ACHE (0.50) | TSHRLMNAALOX12ACHEKCNH2 | |
| Toluene SCHEMBL15192049 | 0.89 | TSHR (0.48) | TSHRLMNAALOX12ACHEKCNH2 | |
| Heptane SCHEMBL6470761 | 0.89 | KCNH2 (0.55) | TSHRLMNAALOX12ACHEKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286624-A | Preparation method of thiamethoxam | 内蒙古犇星化学有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-114621099-A | Preparation method of quaternary ammonium salt ionic liquid corrosion inhibitor | 辽宁科技学院 | 2022-06-14 | — | — | CN | claimed |
| US-20210060106-A1 | METHOD FOR OBTAINING SAPONINS FROM PLANTS | DESERT KING CHILE S.A. (CL) | 2021-03-04 | — | — | US | claimed |
| CN-109092338-B | Preparation method and application of vanadyl phosphate catalyst | 中国科学院过程工程研究所 | 2020-07-28 | — | — | CN | claimed |
| CN-106831416-B | A kind of preparation method of high-content TrinexAN_SNacethyl raw medicine | 淮安国瑞化工有限公司 | 2019-11-08 | — | — | CN | claimed |
| CN-109553571-A | The method of chloro--methylpyridine is continuously prepared in a kind of microchannel | 内蒙古元正精细化工有限责任公司 | 2019-04-02 | — | — | CN | claimed |
| CN-107337665-A | A kind of synthetic method with triazole ring structure immunosuppressive drug | 淄博职业学院 | 2017-11-10 | — | — | CN | claimed |
| CN-102936263-A | Novel synthetic phospholipid and application thereof | LIYANG ADVANCED VEHICLE TECHNOLOGY CO LTD | 2013-02-20 | — | — | CN | claimed |
| CN-101362779-B | Synthesis method of octaphenyltetrasiloxanyl cyclic ether | UNIV HEFEI TECHNOLOGY | 2011-03-16 | — | — | CN | claimed |
| CN-101362779-A | Synthesis method of octaphenyltetrasiloxanyl cyclic ether | UNIV HEFEI TECHNOLOGY (CN) | 2009-02-11 | — | — | CN | claimed |
| CN-1301240-C | Preparation and use of fluorescent marking reagent 2-naphthoxy acetyl chloride | NUCLEAR MEDICAL INST JIANGSU (CN) | 2007-02-21 | — | — | CN | claimed |
| CN-1645144-A | Preparation and use of fluorescent marking reagent 2-naphthoxy acetyl chloride | NUCLEAR MEDICAL INST JIANGSU (CN) | 2005-07-27 | — | — | CN | claimed |
| US-20040249099-A1 | Acrylic esters of 2-cyano-2, 4 pentenedioic acid | CHEMENCE, INC. | 2004-12-09 | — | — | US | claimed |
| EP-0362309-B1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS | SOCHINAZ, SOCIETE CHIMIQUE DE VIONNAZ S.A. (CH) | 1992-09-23 | — | — | EP | claimed |
| WO-1992009651-A1 | POLYCYANOACRYLATE FOAM | CHEMENCE LIMITED (GB) | 1992-06-11 | — | — | WO | claimed |
| US-5104995-A | Multistage reactions for preparing 2-(4-(3-oxocyclohexyl) phenyl) propionic acid | SOCHINAZ, SOCIETE CHIMIQUE DE VIOMAZ S.A. (CH) | 1992-04-14 | — | — | US | claimed |
| EP-0362309-A1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS. | SOCHINAZ SOCIETE CHIMMIQUE DE (CH) | 1990-04-11 | — | — | EP | claimed |
| WO-1989009215-A1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS | SOCHINAZ, SOCIETE CHIMIQUE DE VIONNAZ S.A. (CH) | 1989-10-05 | — | — | WO | claimed |
| US-4374291-A | Synthesis of bis(ethynylphenyl) compounds | HUGHES AIRCRAFT COMPANY (US) | 1983-02-15 | — | — | US | claimed |
| CN-115710217-B | Flunixin meglumine synthesis method suitable for industrial production | 江苏恒盛药业有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-110875348-B | Display apparatus | 三星显示有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118255748-A | Method for recycling and applying tetrazole reaction solvent | 浙江华海药业股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-11912659-B2 | EBNA1 inhibitors and methods using same | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2024-02-27 | — | — | US | disclosed |
| EP-4273624-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS, INTERLAYER INSULATING FILM, SURFACE PROTECTION FILM, AND ELECTRONIC COMPONENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-08 | — | — | EP | disclosed |
| EP-3717494-B1 | HIGHLY ISOSELECTIVE CATALYST FOR ALKENE HYDROFORMYLATION | EASTMAN CHEM CO (US) | 2023-11-01 | — | — | EP | disclosed |
| CN-116715586-A | Recovery method of acid binding agent triethylamine in preparation process of 5-nonylsalicylaldehyde | 福建紫金选矿药剂有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-108341960-B | Dynamic polymer containing combined dynamic covalent bonds and application thereof | 厦门天策材料科技有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-108341961-B | Preparation and application of dynamic polymer containing combined dynamic covalent bonds | 厦门天策材料科技有限公司 | 2023-08-25 | — | — | CN | disclosed |
| US-11672758-B2 | Endoxifen methods and compositions for inhibition of protein kinase C | JINA PHARMACEUTICALS, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| CN-115894873-A | Polymer with HLCT (high-intensity-scanning-Current computed tomography) property, preparation method and application thereof, organic light-emitting diode and display panel | 中国科学院宁波材料技术与工程研究所 | 2023-04-04 | — | — | CN | disclosed |
| CN-115286624-A | Preparation method of thiamethoxam | 内蒙古犇星化学有限公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-114621099-A | Preparation method of quaternary ammonium salt ionic liquid corrosion inhibitor | 辽宁科技学院 | 2022-06-14 | — | — | CN | disclosed |
| US-20220115567-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-14 | — | — | US | disclosed |
| US-11227980-B2 | Display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-18 | — | — | US | disclosed |
| CN-113149885-A | EBNA1 inhibitors and methods of using the same | 威斯塔解剖学和生物学研究所 | 2021-07-23 | — | — | CN | disclosed |
| EP-3294705-B1 | EBNA1 INHIBITORS AND METHODS USING SAME | WISTAR INST (US) | 2021-07-21 | — | — | EP | disclosed |
| US-20210177752-A1 | ENDOXIFEN METHODS AND COMPOSITIONS FOR INHIBITION OF PROTEIN KINASE C | JINA PHARMACEUTICALS, INC. | 2021-06-17 | — | — | US | disclosed |
| US-10981867-B2 | EBNA1 inhibitors and methods using same | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2021-04-20 | — | — | US | disclosed |
| CN-109721567-B | Catalyst and method for preparing glycidyl methacrylate by catalysis | 万华化学集团股份有限公司 | 2021-02-02 | — | — | CN | disclosed |
| EP-3717494-A1 | HIGHLY ISOSELECTIVE CATALYST FOR ALKENE HYDROFORMYLATION | Eastman Chemical Company (US) | 2020-10-07 | — | — | EP | disclosed |
| EP-3717120-A1 | HIGHLY ISOSELECTIVE CATALYST FOR ALKENE HYDROFORMYLATION | Eastman Chemical Company (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200239415-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | WISTAR INST (US) | 2020-07-30 | — | — | US | disclosed |
| CN-110875348-A | Display device | 三星显示有限公司 | 2020-03-10 | — | — | CN | disclosed |
| US-20200075814-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-05 | — | — | US | disclosed |
| CN-110431203-A | Organosilicon, composition through ion modification and the medical equipment formed by it | MOMENTIVE PERFORMANCE MAT INC | 2019-11-08 | — | — | CN | disclosed |
| CN-110418796-A | The glucosiduronate prodrug of tropsch imatinib (TOFACITINIB) | THERAVANCE BIOPHARMA R&D IP LLC | 2019-11-05 | — | — | CN | disclosed |
| US-10442763-B2 | EBNA1 inhibitors and methods using same | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2019-10-15 | — | — | US | disclosed |
| CN-107290453-B | The HPLC analysis method of palonosetron Hcl synthesis intermediate product | 方达医药技术(上海)有限公司 | 2019-09-17 | — | — | CN | disclosed |
| US-10376479-B2 | Endoxifen compositions and methods | JINA PHARMACEUTICALS, INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20190231687-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES | JINA PHARMACEUTICALS, INC. | 2019-08-01 | — | — | US | disclosed |
| US-10351583-B2 | Highly isoselective catalyst for alkene hydroformylation | EASTMAN CHEMICAL COMPANY (US) | 2019-07-16 | — | — | US | disclosed |
| CN-109935553-A | Packaging plastic and encapsulating structure | TCL集团股份有限公司 | 2019-06-25 | — | — | CN | disclosed |
| US-20190161508-A1 | HIGHLY ISOSELECTIVE CATALYST FOR ALKENE HYDROFORMYLATION | EASTMAN CHEMICAL COMPANY (US) | 2019-05-30 | — | — | US | disclosed |
| CN-109311890-A | BET protein degradation agent | 密执安大学评议会 | 2019-02-05 | — | — | CN | disclosed |
| US-10183961-B1 | Highly isoselective catalyst for alkene hydroformylation | EASTMAN CHEMICAL COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| US-10144751-B1 | Highly isoselective catalyst for alkene hydroformylation | EASTMAN CHEMICAL COMPANY (US) | 2018-12-04 | — | — | US | disclosed |
| US-20180305312-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-10-25 | — | — | US | disclosed |
| CN-104884059-B | Mixing pedigree kinase inhibitor for HIV/AIDS treatments | 罗切斯特大学 | 2018-08-10 | — | — | CN | disclosed |
| CN-108341960-A | It is a kind of to contain the dynamic aggregation object for combining dynamic covalent bond and its application | 翁秋梅 | 2018-07-31 | — | — | CN | disclosed |
| CN-108341961-A | A kind of preparation of dynamic aggregation object and its application containing combination dynamic covalent bond | 翁秋梅 | 2018-07-31 | — | — | CN | disclosed |
| CN-105601976-B | Method for preparing antibacterial surface on surface of biomedical material | 苏州大学 | 2018-07-03 | — | — | CN | disclosed |
| EP-3294705-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | The Wistar Institute Of Anatomy And Biology (US) | 2018-03-21 | — | — | EP | disclosed |
| EP-3105239-B1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOBISPHOSPHITES | EVONIK DEGUSSA GMBH (DE) | 2018-03-14 | — | — | EP | disclosed |
| EP-2101731-B1 | ENDOXIFEN FOR USE IN THE TREATMENT OF CANCER | JINA PHARMACEUTICALS INC (US) | 2018-01-31 | — | — | EP | disclosed |
| CN-107383087-A | For preparing the high selective method of organodiphosphite | 英威达纺织（英国）有限公司 | 2017-11-24 | — | — | CN | disclosed |
| CN-107382989-A | A kind of synthetic method with oxazole ring structure immunosuppressive drug | 河南科技大学第附属医院 | 2017-11-24 | — | — | CN | disclosed |
| CN-107311994-A | A kind of novel method for synthesizing of the receptor stimulating agent drug molecules of S1P 1 | 淄博职业学院 | 2017-11-03 | — | — | CN | disclosed |
| CN-104159616-B | Chewing gum for diagnosing inflammatory tissue in dental applications | 托门医学股份公司 | 2017-10-31 | — | — | CN | disclosed |
| CN-107298677-A | The preparation method and application of evil azole compounds with immunosuppressive activity | 侯茜茜 | 2017-10-27 | — | — | CN | disclosed |
| CN-107290453-A | The HPLC analysis methods of palonosetron Hcl synthetic mesophase product | 南京普氟生物检测技术有限公司 | 2017-10-24 | — | — | CN | disclosed |
| CN-105289532-B | A kind of vitamin B12 molecular engram solid phase extraction magnetic material and its preparation method and application | 华南理工大学 | 2017-10-20 | — | — | CN | disclosed |
| WO-2017108972-A1 | COMPOUNDS OF R-(-)-(E)-[4-(2,4-DICHLOROPHENYL)-1,3-DITHIOLAN-2-YLIDENE]-1 -IMIDAZOLYLACETONITRILE-HA (LULICONAZOLE-HA) AS ANTIFUNGALS | LABORATORIOS LESVI, S.L. (ES) | 2017-06-29 | — | — | WO | disclosed |
| EP-3105239-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOBISPHOSPHITES | Evonik Degussa GmbH (DE) | 2016-12-21 | — | — | EP | disclosed |
| US-20160346230-A1 | Endoxifen Compositions And Methods | JINA PHARMACEUTICALS, INC. | 2016-12-01 | — | — | US | disclosed |
| WO-2016183534-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2016-11-17 | — | — | WO | disclosed |
| CN-105924645-A | Halogen-free expanding flame retardant containing polymeric macromolecule triazine rings and preparation method of halogen-free expanding flame retardant | 南京林业大学 | 2016-09-07 | — | — | CN | disclosed |
| CN-105732703-A | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | 因温斯特技术公司 | 2016-07-06 | — | — | CN | disclosed |
| US-9333190-B2 | Endoxifen compositions and methods | JINA PHARMACEUTICALS, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| CN-104292141-B | Macromole hindered phenol antioxygen of Sulfide-containing Hindered and carbamate groups and preparation method thereof and application | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2016-03-02 | — | — | CN | disclosed |
| CN-105289532-A | Molecularly-imprinted solid-phase extraction magnetic material for vitamin B12 and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2016-02-03 | — | — | CN | disclosed |
| CN-105175750-A | Preparation method of aquagel microspheres | UNIV HENAN TECHNOLOGY | 2015-12-23 | — | — | CN | disclosed |
| CN-101365501-B | Hydrophilic coatings comprising polyelectrolytes | DSM IP ASSETS B.V. (NL) | 2015-12-16 | — | — | CN | disclosed |
| CN-102936263-B | Synthetic phospholipid that one class is novel and uses thereof | A.V.T.(LIYANG) MEDICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2015-11-25 | — | — | CN | disclosed |
| CN-104955803-A | Preparation of 3-amino-piperidine compounds via nitro-tetrahydropyridine precursors | LEK PHARMACEUTICALSD D | 2015-09-30 | — | — | CN | disclosed |
| WO-2015121007-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOBISPHOSPHITES | EVONIK DEGUSSA GMBH (DE) | 2015-08-20 | — | — | WO | disclosed |
| CN-104804203-A | Preparation method of hydrogel microspheres | UNIV HENAN TECHNOLOGY | 2015-07-29 | — | — | CN | disclosed |
| CN-101622020-B | Hydrophilic coating | DSM IP ASSETS BV | 2015-07-01 | — | — | CN | disclosed |
| CN-102964378-B | Preparation of phosphatidylethanolamine | A V T LIYANG MEDICAL SCIENCE & TECHNOLOGY CO LTD | 2015-05-20 | — | — | CN | disclosed |
| EP-2149560-B1 | 1-SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND | ASTELLAS PHARMA INC (JP) | 2015-05-13 | — | — | EP | disclosed |
| CN-104292141-A | Macromolecular hindered phenol antioxidant containing thioether and carbamate groups and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2015-01-21 | — | — | CN | disclosed |
| WO-2015000935-A1 | FLUORINATION PROCESS | SOLVAY SA (BE) | 2015-01-08 | — | — | WO | disclosed |
| CN-101622019-B | Hydrophilic coating | DSM IP ASSETS BV | 2015-01-07 | — | — | CN | disclosed |
| EP-2821388-A1 | Fluorination process | Solvay SA (BE) | 2015-01-07 | — | — | EP | disclosed |
| CN-103642033-A | Guerbet alcohol nonionic surfactant | UNIV NANJING SCIENCE & TECH | 2014-03-19 | — | — | CN | disclosed |
| US-8557982-B2 | Tubulin polymerisation inhibitors | BIONOMICS LIMITED (AU) | 2013-10-15 | — | — | US | disclosed |
| EP-2573833-A1 | Organic semiconductors, their manufacture and semiconductor devices comprising them | BASF SE (DE) | 2013-03-27 | — | — | EP | disclosed |
| CN-102964378-A | Preparation of phosphatidylethanolamine | A V T LIYANG MEDICAL SCIENCE & TECHNOLOGY CO LTD | 2013-03-13 | — | — | CN | disclosed |
| CN-102936263-A | Novel synthetic phospholipid and application thereof | LIYANG ADVANCED VEHICLE TECHNOLOGY CO LTD | 2013-02-20 | — | — | CN | disclosed |
| US-8344007-B2 | Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2013-01-01 | — | — | US | disclosed |
| US-20120309768-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | BIONOMICS LIMITED (AU) | 2012-12-06 | — | — | US | disclosed |
| CN-101945898-B | Catalyst component for ethylene polymerization and process for producing ethylene polymer (2) | SUMITOMO CO LTD | 2012-10-10 | — | — | CN | disclosed |
| US-8278290-B2 | Tubulin polymerisation inhibitors | Biononics Limited (AU) | 2012-10-02 | — | — | US | disclosed |
| US-8263607-B2 | 1-substituted tetrahydroisoquinoline compound | ASTELLAS PHARMA INC. (JP) | 2012-09-11 | — | — | US | disclosed |
| CN-101855251-B | Triethylamine functionalized elastomers for barrier applications | EXXON MOBIL CHEM PATENTS INC | 2012-09-05 | — | — | CN | disclosed |
| US-20120164075-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES | JINA PHARMACEUTICALS, INC. (US) | 2012-06-28 | — | — | US | disclosed |
| CN-102405226-A | Highly selective process for the preparation of organodiphosphites | INVISTA TECH SARL | 2012-04-04 | — | — | CN | disclosed |
| CN-102405225-A | Highly selective process for the preparation of organodiphosphites | INVISTA TECH SARL | 2012-04-04 | — | — | CN | disclosed |
| EP-2432462-A2 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES | Jina Pharmaceuticals Inc. (US) | 2012-03-28 | — | — | EP | disclosed |
| US-8101776-B2 | Organic semiconductors and their manufacture | BASF SE (DE) | 2012-01-24 | — | — | US | disclosed |
| EP-2363390-A1 | DERIVED LACTAM FROM D3 VITAMIN | Teijin Pharma Limited (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | TEIJIN PHARMA LIMITED (JP) | 2011-08-25 | — | — | US | disclosed |
| US-7910579-B2 | Benzoxazole derivatives | TOHOKU UNIVERSITY (JP) | 2011-03-22 | — | — | US | disclosed |
| CN-101970583-A | Hydrophilic coating | DSM IP ASSETS BV | 2011-02-09 | — | — | CN | disclosed |
| CN-101945898-A | Catalyst component for ethylene polymerization and process for producing ethylene polymer (2) | SUMITOMO CHEMICAL CO | 2011-01-12 | — | — | CN | disclosed |
| WO-2010135703-A2 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES | JINA PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20100292190-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | BIONOMICS LIMITED (AU) | 2010-11-18 | — | — | US | disclosed |
| US-20100273840-A1 | WATER-SOLUBLE POLYMER-BASED CANTHARIMIDES AS POTENTIALLY SELECTIVE ANTI-TUMOR AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2010-10-28 | — | — | US | disclosed |
| CN-101855251-A | Triethylamine functionalized elastomers for barrier applications | EXXONMOBIL CHEM PATENTS INC | 2010-10-06 | — | — | CN | disclosed |
| WO-2010100413-A2 | CROSS-LINKABLE POLYMERS | OXFORD ADVANCED SURFACES LTD (GB) | 2010-09-10 | — | — | WO | disclosed |
| CN-101784540-A | alcohols containing imide moieties and reactive oligomers prepared therefrom | NAT STARCH CHEM INVEST | 2010-07-21 | — | — | CN | disclosed |
| US-20100168154-A1 | 1-SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2010-07-01 | — | — | US | disclosed |
| CN-1990528-B | Method for functionalization on magnetic nano particle surface | CHENGDU ORGANIC CHEMICALS CO | 2010-06-16 | — | — | CN | disclosed |
| US-20100112041-A1 | Endoxifen Compositions And Methods | JINA PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2149560-A1 | 1-SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND | Astellas Pharma Inc. (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | TOHOKU UNIVERSITY (JP) | 2010-01-28 | — | — | US | disclosed |
| CN-101622019-A | Hydrophilic coating | DSM IP ASSETS BV | 2010-01-06 | — | — | CN | disclosed |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | CLAP CO., LTD. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090291134-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES | JINA PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | disclosed |
| EP-2103611-A1 | BENZOXAZOLE DERIVATIVES | Tohoku University (JP) | 2009-09-23 | — | — | EP | disclosed |
| EP-2101731-A2 | ENDOXIFEN METHODS AND COMPOSITIONS | Jina Pharmaceuticals Inc. (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2009083724-A1 | PROCESSES FOR THE PREPARATION OF THALIDOMIDE | CIPLA LIMITED (IN) | 2009-07-09 | — | — | WO | disclosed |
| US-7504530-B2 | Methods for the preparation of fispemifene from ospemifene | HORMOS MEDICAL LTD. (FI) | 2009-03-17 | — | — | US | disclosed |
| CN-101365501-A | Hydrophilic coatings comprising polyelectrolytes | DSM IP ASSETS BV (NL) | 2009-02-11 | — | — | CN | disclosed |
| WO-2008070463-A9 | ENDOXIFEN METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2008-09-18 | — | — | WO | disclosed |
| US-20080214860-A1 | METHODS FOR THE PREPARATION OF FISPEMIFENE FROM OSPEMIFENE | QUATRX PHARMACEUTICALS COMPANY | 2008-09-04 | — | — | US | disclosed |
| EP-1961052-A1 | ORGANIC SEMICONDUCTORS AND THEIR MANUFACTURE | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-08-27 | — | — | EP | disclosed |
| WO-2008070463-A2 | ENDOXIFEN METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| CN-101137636-A | Exo-selective synthesis of himbacine analogs | SCHERING CORP (US) | 2008-03-05 | — | — | CN | disclosed |
| EP-1848704-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | Bionomics Limited (AU) | 2007-10-31 | — | — | EP | disclosed |
| CN-1990528-A | Method for functionalization on magnetic nano particle surface | CHENGDU ORGANIC CHEMICALS CO (CN) | 2007-07-04 | — | — | CN | disclosed |
| WO-2007068618-A1 | ORGANIC SEMICONDUCTORS AND THEIR MANUFACTURE | CIBA HOLDING INC. (CH) | 2007-06-21 | — | — | WO | disclosed |
| CN-1968922-A | Factor XA inhibitors | MILLENNIUM PHARM INC (US) | 2007-05-23 | — | — | CN | disclosed |
| CN-1301240-C | Preparation and use of fluorescent marking reagent 2-naphthoxy acetyl chloride | NUCLEAR MEDICAL INST JIANGSU (CN) | 2007-02-21 | — | — | CN | disclosed |
| US-7125942-B2 | Acrylic esters of 2-cyano-2, 4 pentenedioic acid | CLAST TRADING LTD (HK) | 2006-10-24 | — | — | US | disclosed |
| EP-1705169-A2 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | Hormos Medical Ltd. (FI) | 2006-09-27 | — | — | EP | disclosed |
| WO-2006084338-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | BIONOMICS LIMITED (AU) | 2006-08-17 | — | — | WO | disclosed |
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| CN-1249054-C | Process for preparation of aripiprazole | CHONGQING PHARM RES INST CO (CN) | 2006-04-05 | — | — | CN | disclosed |
| EP-1235776-B1 | TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | HORMOS MEDICAL CORP (FI) | 2006-02-08 | — | — | EP | disclosed |
| CN-1235880-C | Quinolinenone kind derivative and its accetable salt, its preparation method, application in preparation of alipyrazole and preparation of alipyrazole | CHONGQING MEDICINE INDUSTRY IN (CN) | 2006-01-11 | — | — | CN | disclosed |
| CN-1649849-A | Tachykinin receptor antagonists | LILLY CO ELI (US) | 2005-08-03 | — | — | CN | disclosed |
| CN-1645144-A | Preparation and use of fluorescent marking reagent 2-naphthoxy acetyl chloride | NUCLEAR MEDICAL INST JIANGSU (CN) | 2005-07-27 | — | — | CN | disclosed |
| US-6875775-B2 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | HORMOS MEDICAL OY LTD (FI) | 2005-04-05 | — | — | US | disclosed |
| CN-1576273-A | Process for Producing Aliprazo | CHONGQING MEDICAL INDUSTRY RES (CN) | 2005-02-09 | — | — | CN | disclosed |
| CN-1569845-A | Process for preparation of aripiprazole | CHONGQING PHARM RES INST CO (CN) | 2005-01-26 | — | — | CN | disclosed |
| EP-1487848-A2 | A BUILDING BLOCK FORMING A C=C DOUBLE BOND UPON REACTION | Nuevolution A/S (DK) | 2004-12-22 | — | — | EP | disclosed |
| US-20040249099-A1 | Acrylic esters of 2-cyano-2, 4 pentenedioic acid | CHEMENCE, INC. | 2004-12-09 | — | — | US | disclosed |
| CN-1513841-A | Quinolinenone kind derivative and its accetable salt, its preparation method, application in preparation of alipyrazole and preparation of alipyrazole | 重庆医药工业研究院有限责任公司 | 2004-07-21 | — | — | CN | disclosed |
| US-6765092-B2 | OXIDIZING A CHLORIN TO PRODUCE A MIXTURE OF HYDROXYCHLORIN AND OXOCHLORIN, AND THEN OXIDIZING THE HYDROXYCHLORIN, PREFERABLY WITH DDQ | NORTH CAROLINA STATE UNIVERSITY | 2004-07-20 | — | — | US | disclosed |
| CN-1507436-A | Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers | — | 2004-06-23 | — | — | CN | disclosed |
| US-20030225130-A1 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | HORMOS MEDICAL OY LTD. | 2003-12-04 | — | — | US | disclosed |
| WO-2003078445-A2 | A BUILDING BLOCK FORMING A C=C DOUBLE BOND UPON REACTION | NUEVOLUTION A/S (DK) | 2003-09-25 | — | — | WO | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| US-6576645-B1 | Such as 3-(4-chloro-1-(4-(2-(2-hydroxyethoxy)ethoxy)phenyl)--2-phenylbut-1 -enyl)phenol; producing tissue specific estro-genic and/or antiestrogenic effect | HORMOS MEDICAL OY LTD (FI) | 2003-06-10 | — | — | US | disclosed |
| US-20020137925-A1 | Regioisomerically pure oxochlorins and methods of synthesis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-26 | — | — | US | disclosed |
| EP-1235776-A1 | TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | Hormos Medical Corporation (FI) | 2002-09-04 | — | — | EP | disclosed |
| US-6426395-B1 | SUCH AS OXO-BIS-(DIMETHYLSILYLENE-BIS(2,3,5-TRIMETHYLCYCLOPENTADIENYL)ZIRCONIUM CHLORIDE); CRYSTALLIZATION/ CRYSTAL STRUCTURE | CHISSO CORPORATION (JP) | 2002-07-30 | — | — | US | disclosed |
| CN-1355697-A | IL-8 receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 2002-06-26 | — | — | CN | disclosed |
| EP-1169316-A1 | NOVEL LIPOIC ACID DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-01-09 | — | — | EP | disclosed |
| CN-1066311-C | Method for preparing acaricide Kemante | CHENGSHI CHENGXIN COMMERCIAL T (CN) | 2001-05-30 | — | — | CN | disclosed |
| WO-2001036360-A1 | TRIPHENYLALKENE DERIVATIVES AND THEIR USE AS SELECTIVE ESTROGEN RECEPTOR MODULATORS | HORMOS MEDICAL CORPORATION (FI) | 2001-05-25 | — | — | WO | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |
| US-6180625-B1 | MODULATING AND NORMALIZING AN IMPAIRED HAEMOSTATIC BALANCE IN A MAMMAL, WHICH METHOD COMPRISES ADMINISTERING AN EFFECTIVE AMOUNT OF NOVEL BENZOXAZIN DERIVATIVES; ANTICOAGULANTS | NOVO NORDISK A/S (DK) | 2001-01-30 | — | — | US | disclosed |
| EP-1054887-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Amgen Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| US-6143769-A | ENANTIOMORPH | KARL THOMAE GMBH (DE) | 2000-11-07 | — | — | US | disclosed |
| WO-2000059899-A1 | NOVEL LIPOIC ACID DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SOCIETE DE CONSEIL DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-10-12 | — | — | WO | disclosed |
| CN-1048722-C | (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof | THOMAE GMBH DR K (DE) | 2000-01-26 | — | — | CN | disclosed |
| WO-1999048878-A1 | HETEROCYCLIC COMPOUNDS REGULATING CLOTTING | NOVO NORDISK A/S (DK) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999040091-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| CN-1041317-C | Monomeric hindered amine esters of monocarboxylic resin acids and olefin polymer compositions stabilized therewith. | HIMONT INC (US) | 1998-12-23 | — | — | CN | disclosed |
| CN-1190532-A | Method for preparing acaricide Kemante | CHENGSHI CHENGXIN COMMERCIAL T (CN) | 1998-08-19 | — | — | CN | disclosed |
| US-5783572-A | TREATMENT OF NEURODEGENERATIVE DISORDERS | PFIZER INC. (US) | 1998-07-21 | — | — | US | disclosed |
| US-5594025-A | Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane | ELI LILLY AND COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5594034-A | ADMINISTERING DIRECT ACTING 5-HYDROXYTRYPTAMINE AGONIST TO MAMMAL | ELI LILLY AND COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| EP-0455510-B1 | Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion | LILLY CO ELI (US) | 1996-11-27 | — | — | EP | disclosed |
| US-5576352-A | Method of inhibiting gastric acid secretion with aryloxypropanolamines | ELI LILLY AND COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1996008468-A1 | CARBAMOYLOXY AMINE COMPOUNDS | H. LUNDBECK A/S (DK) | 1996-03-21 | — | — | WO | disclosed |
| CN-1030699-C | Preparation method of trifluoropropene compound | AMERICAN CYANAMID CO (US) | 1996-01-17 | — | — | CN | disclosed |
| US-5457120-A | Antisecretory and antiserotonine agents | ELI LILLY AND COMPANY (US) | 1995-10-10 | — | — | US | disclosed |
| WO-1995007278-A1 | FUNGICIDAL, MITICIDAL AND ARTHROPODICIDAL AMINOPYRIMIDINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-03-16 | — | — | WO | disclosed |
| US-5340838-A | Administering serotonin agonist to mammals | ELI LILLY AND COMPANY (US) | 1994-08-23 | — | — | US | disclosed |
| US-5312924-A | Compounds for lowering blood sugar and effecting metabolism | DR. KARL THOMAE GMBH (DE) | 1994-05-17 | — | — | US | disclosed |
| US-5258379-A | ADMINISTERING IN AN EFFECTIVE DOSAGE TO MAMMALS | ELI LILLY AND COMPANY (US) | 1993-11-02 | — | — | US | disclosed |
| US-5245060-A | Reaction of terpene and iminoalkanoate, complex rhodium catalyst | EISAI CO. LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| CN-1072694-A | Monocarboxylic acid resinous acid and with the monomeric hindered amine esters of its stable olefin polymer compositions | HIMONT INC (US) | 1993-06-02 | — | — | CN | disclosed |
| CN-1068820-A | (S) (+)-2-oxyethyl group-4-[N-[1-(2-piperidino-phenyl)-3-methyl isophthalic acid-butyl] amino carbonyl methyl] phenylformic acid, contain pharmaceutical composition of this compound and preparation method thereof | THOMAE GMBH DR K (DE) | 1993-02-10 | — | — | CN | disclosed |
| US-5158956-A | Administering serotonin receptor agonist | ELI LILLY AND COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| EP-0362309-B1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS | SOCHINAZ, SOCIETE CHIMIQUE DE VIONNAZ S.A. (CH) | 1992-09-23 | — | — | EP | disclosed |
| WO-1992009651-A1 | POLYCYANOACRYLATE FOAM | CHEMENCE LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| CN-1059738-A | Monocarboxylate and form with the in addition stable olefin polymer of this ester | HIMONT INC (US) | 1992-03-25 | — | — | CN | disclosed |
| US-5096908-A | 5-HT1A agonist | ELI LILLY AND COMPANY (US) | 1992-03-17 | — | — | US | disclosed |
| CN-1058587-A | Insecticidal acaricidal and nematicidal 2-aryl-5- (trifluoromethyl) pyrrole compounds | AMERICAN CYANAMID CO (US) | 1992-02-12 | — | — | CN | disclosed |
| EP-0460924-A1 | Dichloroaniline compound | GLAXO GROUP LIMITED (GB) | 1991-12-11 | — | — | EP | disclosed |
| EP-0455510-A2 | Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion | ELI LILLY AND COMPANY (US) | 1991-11-06 | — | — | EP | disclosed |
| EP-0362309-A1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS. | SOCHINAZ SOCIETE CHIMMIQUE DE (CH) | 1990-04-11 | — | — | EP | disclosed |
| US-4891168-A | Process for producing steroid derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1990-01-02 | — | — | US | disclosed |
| WO-1989009215-A1 | (ETHYLENEDIOXO-3,3 CYCLOHEXYL)-4 ACETOPHENONE AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM AND USE OF THESE COMPOUNDS | SOCHINAZ, SOCIETE CHIMIQUE DE VIONNAZ S.A. (CH) | 1989-10-05 | — | — | WO | disclosed |
| US-4814472-A | Diethynylated diphenyl hexafluoropropanes | HUGHES AIRCRAFT COMPANY (US) | 1989-03-21 | — | — | US | disclosed |
| EP-0261656-A1 | A process for producing steroid derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-4508912-A | UNING METAL OXIDE, HYDROXIDE, ACID OR ACID SALT, OR ORGANOBASIC COMPOUND CATALYST | AJINOMOTO COMPANY, INCORPORATED (JP) | 1985-04-02 | — | — | US | disclosed |
| US-4465833-A | ALKYNYLATION HALOGENATED BENZENE COMPOUND IN PRESENCE OF METAL CATALYST | HUGHES AIRCRAFT COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
| US-4374291-A | Synthesis of bis(ethynylphenyl) compounds | HUGHES AIRCRAFT COMPANY (US) | 1983-02-15 | — | — | US | disclosed |
| EP-0050428-A1 | Ethynylated aromatic compounds and process for making same | Hughes Aircraft Company (US) | 1982-04-28 | — | — | EP | disclosed |
| EP-0050428-A1 | Ethynylated aromatic compounds and process for making same | Hughes Aircraft Company (US) | 1982-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100112041-A1 | Endoxifen Compositions And Methods | CYP46A1, PLA2G2F, VDR | TSHR 3322/4885LMNA 1312/4885ALOX12 138/4885 |
| US-20160346230-A1 | Endoxifen Compositions And Methods | CYP46A1, PLA2G2F, VDR | TSHR 3322/4885LMNA 1312/4885ALOX12 138/4885 |
| US-20200239415-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | MLLT1, EBNA1BP2, MALT1 | TSHR 4040/4885LMNA 897/4885ALOX12 1625/4885 |
| US-20090291134-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES | NLN, BDNF, LITAF | TSHR 2821/4885LMNA 970/4885ALOX12 74/4885 |
| US-10144751-B1 | Highly isoselective catalyst for alkene hydroformylation | NUDT1, AHR, HMOX2 | TSHR 3566/4885LMNA 4177/4885ALOX12 158/4885 |
| US-10376479-B2 | Endoxifen compositions and methods | CYP46A1, PLA2G2F, VDR | TSHR 3322/4885LMNA 1312/4885ALOX12 138/4885 |
| US-20080214860-A1 | METHODS FOR THE PREPARATION OF FISPEMIFENE FROM OSPEMIFENE | CTSF, CTSE, MME | TSHR 3999/4885LMNA 1918/4885ALOX12 2130/4885 |
| US-20180305312-A1 | EBNA1 INHIBITORS AND METHODS USING SAME | MLLT1, EBNA1BP2, MALT1 | TSHR 4040/4885LMNA 897/4885ALOX12 1625/4885 |
| US-20210060106-A1 | METHOD FOR OBTAINING SAPONINS FROM PLANTS | LSS, GYS2, GYPA | TSHR 2877/4885LMNA 1314/4885ALOX12 3304/4885 |
| US-20120164075-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES | ENPP2, ERAL1, LITAF | TSHR 2970/4885LMNA 728/4885ALOX12 78/4885 |
| US-20190231687-A1 | ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF PSYCHIATRIC AND NEURODEGENERATIVE DISEASES | NLN, BDNF, LITAF | TSHR 2821/4885LMNA 970/4885ALOX12 74/4885 |
| US-20030225130-A1 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators | ESR2, ESR1, GPER1 | TSHR 59/4885LMNA 4585/4885ALOX12 1674/4885 |
| US-20100292190-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | TUBB1, TUBA1C, TUBB | TSHR 4488/4885LMNA 2644/4885ALOX12 4874/4885 |
| US-20210177752-A1 | ENDOXIFEN METHODS AND COMPOSITIONS FOR INHIBITION OF PROTEIN KINASE C | EEF2K, LITAF, RAPGEF3 | TSHR 3254/4885LMNA 948/4885ALOX12 891/4885 |
| US-10351583-B2 | Highly isoselective catalyst for alkene hydroformylation | NUDT1, AHR, HMOX2 | TSHR 3566/4885LMNA 4177/4885ALOX12 158/4885 |
| US-10981867-B2 | EBNA1 inhibitors and methods using same | MLLT1, EBNA1BP2, MALT1 | TSHR 4040/4885LMNA 897/4885ALOX12 1625/4885 |
| US-10183961-B1 | Highly isoselective catalyst for alkene hydroformylation | ADH1A, ADH5, HACL2 | TSHR 4248/4885LMNA 4020/4885ALOX12 250/4885 |
| US-20190161508-A1 | HIGHLY ISOSELECTIVE CATALYST FOR ALKENE HYDROFORMYLATION | NUDT1, AHR, HMOX2 | TSHR 3566/4885LMNA 4177/4885ALOX12 158/4885 |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | YBX1, CDYL, PROX1 | TSHR 4313/4885LMNA 3254/4885ALOX12 3765/4885 |
| US-20100021385-A1 | BENZOXAZOLE DERIVATIVES | CBX7, KIT, BMX | TSHR 3935/4885LMNA 10/4885ALOX12 3388/4885 |
| US-20100168154-A1 | 1-SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND | CACNA1S, CACNA1E, CACNA1B | TSHR 3390/4885LMNA 2055/4885ALOX12 2436/4885 |
| US-20100273840-A1 | WATER-SOLUBLE POLYMER-BASED CANTHARIMIDES AS POTENTIALLY SELECTIVE ANTI-TUMOR AGENTS | HRH3, OXGR1, OXSR1 | TSHR 1164/4885LMNA 4674/4885ALOX12 1743/4885 |
| US-20020137925-A1 | Regioisomerically pure oxochlorins and methods of synthesis | DDT, AOC1, DNMT1 | TSHR 3249/4885LMNA 3578/4885ALOX12 336/4885 |
| US-11672758-B2 | Endoxifen methods and compositions for inhibition of protein kinase C | EEF2K, LITAF, RAPGEF3 | TSHR 3254/4885LMNA 948/4885ALOX12 891/4885 |
| US-20120309768-A1 | NOVEL TUBULIN POLYMERISATION INHIBITORS | TUBB1, TUBA1C, TUBB | TSHR 4488/4885LMNA 2644/4885ALOX12 4874/4885 |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | VDR, CYP24A1, CYP2R1 | TSHR 1981/4885LMNA 942/4885ALOX12 392/4885 |
| US-11912659-B2 | EBNA1 inhibitors and methods using same | MLLT1, EBNA1BP2, MALT1 | TSHR 4040/4885LMNA 897/4885ALOX12 1625/4885 |
| US-10442763-B2 | EBNA1 inhibitors and methods using same | MLLT1, EBNA1BP2, MALT1 | TSHR 4040/4885LMNA 897/4885ALOX12 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.